- Home
- NECB vs LYEL Comparison
NECB vs LYEL Comparison
Compare NECB & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NECB
- LYEL
- Stock Information
- Founded
- NECB 1934
- LYEL 2018
- Country
- NECB United States
- LYEL United States
- Employees
- NECB N/A
- LYEL N/A
- Industry
- NECB Savings Institutions
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- NECB Finance
- LYEL Health Care
- Exchange
- NECB Nasdaq
- LYEL Nasdaq
- Market Cap
- NECB 282.4M
- LYEL 253.2M
- IPO Year
- NECB N/A
- LYEL 2021
- Fundamental
- Price
- NECB $20.23
- LYEL $18.13
- Analyst Decision
- NECB
- LYEL Hold
- Analyst Count
- NECB 0
- LYEL 3
- Target Price
- NECB N/A
- LYEL $16.67
- AVG Volume (30 Days)
- NECB 49.2K
- LYEL 38.4K
- Earning Date
- NECB 10-23-2025
- LYEL 11-12-2025
- Dividend Yield
- NECB 3.96%
- LYEL N/A
- EPS Growth
- NECB N/A
- LYEL N/A
- EPS
- NECB 3.29
- LYEL N/A
- Revenue
- NECB $103,145,000.00
- LYEL $60,000.00
- Revenue This Year
- NECB $1.90
- LYEL N/A
- Revenue Next Year
- NECB $6.93
- LYEL N/A
- P/E Ratio
- NECB $6.14
- LYEL N/A
- Revenue Growth
- NECB N/A
- LYEL 11.11
- 52 Week Low
- NECB $19.41
- LYEL $7.65
- 52 Week High
- NECB $31.72
- LYEL $30.00
- Technical
- Relative Strength Index (RSI)
- NECB 46.96
- LYEL 64.41
- Support Level
- NECB $20.00
- LYEL $16.00
- Resistance Level
- NECB $20.63
- LYEL $18.09
- Average True Range (ATR)
- NECB 0.59
- LYEL 1.16
- MACD
- NECB 0.05
- LYEL -0.10
- Stochastic Oscillator
- NECB 48.15
- LYEL 69.41
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.